1,2-dichloroethane decreases expression ISO Vegfd (Mus musculus) 6480464 ethylene dichloride results in decreased expression of VEGFD mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Vegfd (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of VEGFD mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO VEGFD (Homo sapiens) 6480464 Dinitrochlorobenzene results in increased expression of VEGFD mRNA CTD PMID:20146380 17beta-estradiol increases expression ISO Vegfd (Mus musculus) 6480464 Estradiol results in increased expression of VEGFD mRNA and Estradiol results in increased expression of VEGFD protein CTD PMID:19484750 and PMID:20615255 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VEGFD mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VEGFD mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO VEGFD (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of VEGFD mRNA CTD PMID:18007998 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Vegfd (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Vegfd (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO VEGFD (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VEGFD mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VEGFD mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VEGFD mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Vegfd (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VEGFD mRNA CTD PMID:22666406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Vegfd (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of VEGFD mRNA CTD PMID:12167310 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO VEGFD (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VEGFD mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Vegfd (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of VEGFD mRNA and AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFD mRNA] CTD PMID:14728982 and PMID:16054899 2-amino-2-deoxy-D-glucopyranose increases expression ISO Vegfd (Mus musculus) 6480464 Glucosamine results in increased expression of VEGFD mRNA CTD PMID:17178593 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of VEGFD mRNA CTD PMID:17109745 24,25-Dihydroxyvitamin D increases expression ISO VEGFD (Homo sapiens) 6480464 24 and 25-Dihydroxyvitamin D 3 results in increased expression of VEGFD protein CTD PMID:18379402 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Vegfd (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of VEGFD mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO Vegfd (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of VEGFD mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Vegfd (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of VEGFD mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO VEGFD (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of VEGFD mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO Vegfd (Mus musculus) 6480464 bisphenol S results in increased expression of VEGFD mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO Vegfd (Mus musculus) 6480464 Fenretinide results in decreased expression of VEGFD mRNA CTD PMID:28973697 aldehydo-D-glucosamine increases expression ISO Vegfd (Mus musculus) 6480464 Glucosamine results in increased expression of VEGFD mRNA CTD PMID:17178593 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of VEGFD mRNA CTD PMID:17109745 aldehydo-D-glucose increases expression ISO Vegfd (Mus musculus) 6480464 Glucose results in increased expression of VEGFD mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO Vegfd (Mus musculus) 6480464 Tretinoin results in decreased expression of VEGFD mRNA CTD PMID:36189433 all-trans-retinoic acid multiple interactions ISO Vegfd (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VEGFD mRNA CTD PMID:36189433 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of VEGFD mRNA CTD PMID:16483693 arsenite(3-) multiple interactions ISO Vegfd (Mus musculus) 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of VEGFD mRNA CTD PMID:15894712 arsenite(3-) decreases expression ISO Vegfd (Mus musculus) 6480464 arsenite results in decreased expression of VEGFD mRNA CTD PMID:15894712 arsenous acid multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFD mRNA CTD PMID:29699374 arsenous acid decreases expression ISO VEGFD (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of VEGFD mRNA CTD PMID:29699374 atorvastatin calcium affects expression ISO VEGFD (Homo sapiens) 6480464 Atorvastatin affects the expression of VEGFD mRNA CTD PMID:16410222 azoxystrobin decreases expression ISO VEGFD (Homo sapiens) 6480464 azoxystrobin results in decreased expression of VEGFD mRNA CTD PMID:33512557 benzalkonium chloride increases expression ISO VEGFD (Homo sapiens) 6480464 Benzalkonium Compounds results in increased expression of VEGFD mRNA CTD PMID:20146380 benzo[a]pyrene multiple interactions ISO Vegfd (Mus musculus) 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of VEGFD mRNA CTD PMID:15894712 benzo[a]pyrene decreases expression ISO Vegfd (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of VEGFD mRNA CTD PMID:15894712 and PMID:27195522 beta-D-glucosamine increases expression ISO Vegfd (Mus musculus) 6480464 Glucosamine results in increased expression of VEGFD mRNA CTD PMID:17178593 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of VEGFD mRNA CTD PMID:17109745 bis(2-ethylhexyl) phthalate decreases expression ISO VEGFD (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of VEGFD mRNA CTD PMID:31163220 bisphenol A increases expression ISO VEGFD (Homo sapiens) 6480464 bisphenol A results in increased expression of VEGFD mRNA CTD PMID:18007998 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VEGFD mRNA CTD PMID:25181051 bisphenol F increases expression ISO Vegfd (Mus musculus) 6480464 bisphenol F results in increased expression of VEGFD mRNA CTD PMID:30951980 bisphenol F decreases expression ISO Vegfd (Mus musculus) 6480464 bisphenol F results in decreased expression of VEGFD mRNA CTD PMID:36706583 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of VEGFD mRNA CTD PMID:32479839 butanal decreases expression ISO VEGFD (Homo sapiens) 6480464 butyraldehyde results in decreased expression of VEGFD mRNA CTD PMID:26079696 carbamazepine affects expression ISO VEGFD (Homo sapiens) 6480464 Carbamazepine affects the expression of VEGFD mRNA CTD PMID:25979313 carbon nanotube affects expression ISO Vegfd (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of VEGFD mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Vegfd (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of VEGFD mRNA CTD PMID:25554681 chloroprene increases expression ISO Vegfd (Mus musculus) 6480464 Chloroprene results in increased expression of VEGFD mRNA CTD PMID:23125180 cisplatin multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of VEGFD mRNA CTD PMID:20705681 clothianidin decreases expression ISO VEGFD (Homo sapiens) 6480464 clothianidin results in decreased expression of VEGFD mRNA CTD PMID:31626844 cordycepin increases secretion ISO VEGFD (Homo sapiens) 6480464 cordycepin results in increased secretion of VEGFD protein CTD PMID:34070360 crocidolite asbestos decreases expression ISO Vegfd (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of VEGFD mRNA CTD PMID:29279043 cycloheximide multiple interactions ISO VEGFD (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VEGFD mRNA] CTD PMID:11007951 cyclosporin A increases expression ISO VEGFD (Homo sapiens) 6480464 Cyclosporine results in increased expression of VEGFD mRNA CTD PMID:33631201 D-glucose increases expression ISO Vegfd (Mus musculus) 6480464 Glucose results in increased expression of VEGFD mRNA CTD PMID:17178593 deguelin decreases expression ISO VEGFD (Homo sapiens) 6480464 deguelin results in decreased expression of VEGFD mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO Vegfd (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of VEGFD mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO VEGFD (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of VEGFD mRNA CTD PMID:28628672 dexamethasone increases expression ISO VEGFD (Homo sapiens) 6480464 Dexamethasone results in increased expression of VEGFD mRNA CTD PMID:25047013 dexamethasone increases expression ISO Vegfd (Mus musculus) 6480464 Dexamethasone results in increased expression of VEGFD mRNA CTD PMID:22733784 dextran sulfate multiple interactions ISO Vegfd (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFD mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO VEGFD (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of VEGFD mRNA CTD PMID:29699374 diarsenic trioxide multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFD mRNA CTD PMID:29699374 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of VEGFD mRNA CTD PMID:16122865 dioxygen multiple interactions ISO VEGFD (Homo sapiens) 6480464 Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFD mRNA] CTD PMID:24292262 dioxygen increases expression ISO VEGFD (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of VEGFD mRNA CTD PMID:24292262 diuron decreases expression EXP 6480464 Diuron results in decreased expression of VEGFD mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO VEGFD (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VEGFD mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of VEGFD mRNA CTD PMID:29391264 fingolimod hydrochloride increases expression ISO Vegfd (Mus musculus) 6480464 Fingolimod Hydrochloride results in increased expression of VEGFD mRNA CTD PMID:24859201 flutamide increases expression EXP 6480464 Flutamide results in increased expression of VEGFD mRNA CTD PMID:24793618 furan increases expression EXP 6480464 furan results in increased expression of VEGFD mRNA CTD PMID:27387713 glucose increases expression ISO Vegfd (Mus musculus) 6480464 Glucose results in increased expression of VEGFD mRNA CTD PMID:17178593 GW 4064 decreases expression ISO Vegfd (Mus musculus) 6480464 GW 4064 results in decreased expression of VEGFD mRNA CTD PMID:26655953 indometacin multiple interactions ISO VEGFD (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of VEGFD mRNA CTD PMID:28628672 isobutyl nitrite increases expression ISO Vegfd (Mus musculus) 6480464 isobutyl nitrite results in increased expression of VEGFD mRNA CTD PMID:16288974 Licochalcone B increases expression ISO VEGFD (Homo sapiens) 6480464 licochalcone B results in increased expression of VEGFD mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO VEGFD (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 manganese(II) chloride increases expression ISO Vegfd (Mus musculus) 6480464 manganese chloride results in increased expression of VEGFD mRNA CTD PMID:17467022 methylmercury chloride decreases expression ISO VEGFD (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of VEGFD mRNA CTD PMID:26272509 methylmercury chloride increases expression ISO VEGFD (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of VEGFD mRNA CTD PMID:28001369 methylmercury chloride multiple interactions ISO VEGFD (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VEGFD mRNA CTD PMID:27188386 microcystin-LR multiple interactions EXP 6480464 [Dietary Fats co-treated with Cholesterol and Dietary co-treated with cyanoginosin LR] results in increased expression of VEGFD mRNA CTD PMID:34740672 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of VEGFD mRNA CTD PMID:34740672 minocycline multiple interactions ISO VEGFD (Homo sapiens) 6480464 Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFD mRNA] CTD PMID:24292262 mono(2-ethylhexyl) phthalate multiple interactions ISO Vegfd (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VEGFD mRNA CTD PMID:36189433 N-methylformamide increases expression ISO Vegfd (Mus musculus) 6480464 methylformamide analog results in increased expression of VEGFD mRNA and methylformamide results in increased expression of VEGFD mRNA CTD PMID:17040096 nickel dichloride increases expression ISO VEGFD (Homo sapiens) 6480464 nickel chloride results in increased expression of VEGFD mRNA CTD PMID:26044615 nickel sulfate increases expression ISO VEGFD (Homo sapiens) 6480464 nickel sulfate results in increased expression of VEGFD mRNA CTD PMID:20146380 ozone multiple interactions ISO Vegfd (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of VEGFD mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of VEGFD mRNA CTD PMID:34911549 p-menthan-3-ol increases expression ISO VEGFD (Homo sapiens) 6480464 Menthol results in increased expression of VEGFD mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of VEGFD mRNA CTD PMID:20705681 PCB138 multiple interactions ISO Vegfd (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 permethrin decreases methylation ISO VEGFD (Homo sapiens) 6480464 Permethrin results in decreased methylation of VEGFD promoter CTD PMID:37047231 permethrin increases expression ISO VEGFD (Homo sapiens) 6480464 Permethrin results in increased expression of VEGFD mRNA CTD PMID:37047231 picoxystrobin decreases expression ISO VEGFD (Homo sapiens) 6480464 picoxystrobin results in decreased expression of VEGFD mRNA CTD PMID:33512557 progesterone affects expression ISO Vegfd (Mus musculus) 6480464 Progesterone affects the expression of VEGFD mRNA CTD PMID:17251523 progesterone increases expression EXP 6480464 Progesterone results in increased expression of VEGFD mRNA CTD PMID:20726854 quercetin increases expression ISO VEGFD (Homo sapiens) 6480464 Quercetin results in increased expression of VEGFD mRNA CTD PMID:21632981 rifampicin multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of VEGFD mRNA CTD PMID:21127053 rotenone increases expression EXP 6480464 Rotenone results in increased expression of VEGFD mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO VEGFD (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of VEGFD mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO VEGFD (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO VEGFD (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VEGFD mRNA CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of VEGFD protein and Silicon Dioxide results in increased expression of VEGFD mRNA CTD PMID:32721576 and PMID:37244296 sodium dodecyl sulfate increases expression ISO VEGFD (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in increased expression of VEGFD mRNA CTD PMID:20146380 sulforaphane decreases expression ISO Vegfd (Mus musculus) 6480464 sulforaphane results in decreased expression of VEGFD mRNA CTD PMID:30529165 tebufenpyrad decreases expression ISO VEGFD (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of VEGFD mRNA CTD PMID:33512557 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of VEGFD mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VEGFD mRNA CTD PMID:32741896 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of VEGFD mRNA CTD PMID:12734012 tetrachloromethane increases expression ISO Vegfd (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of VEGFD mRNA CTD PMID:17484886 thalidomide multiple interactions ISO VEGFD (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Thalidomide] results in decreased expression of VEGFD mRNA CTD PMID:29699374 thalidomide decreases expression ISO VEGFD (Homo sapiens) 6480464 Thalidomide results in decreased expression of VEGFD mRNA CTD PMID:29699374 thifluzamide decreases expression ISO VEGFD (Homo sapiens) 6480464 thifluzamide results in decreased expression of VEGFD mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of VEGFD mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO Vegfd (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFD mRNA CTD PMID:29950665 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of VEGFD mRNA CTD PMID:33387578 troglitazone increases expression ISO Vegfd (Mus musculus) 6480464 troglitazone results in increased expression of VEGFD mRNA CTD PMID:17569031 valproic acid affects expression ISO VEGFD (Homo sapiens) 6480464 Valproic Acid affects the expression of VEGFD mRNA CTD PMID:25979313 valproic acid increases expression ISO Vegfd (Mus musculus) 6480464 Valproic Acid results in increased expression of VEGFD mRNA CTD PMID:24896083 vanadium atom increases expression ISO VEGFD (Homo sapiens) 6480464 Vanadium results in increased expression of VEGFD mRNA CTD PMID:19000753 vanadium(0) increases expression ISO VEGFD (Homo sapiens) 6480464 Vanadium results in increased expression of VEGFD mRNA CTD PMID:19000753 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of VEGFD mRNA CTD PMID:23034163 zinc atom multiple interactions ISO VEGFD (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of VEGFD mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO VEGFD (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of VEGFD mRNA CTD PMID:18593933